Venus Remedies Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Strong return on equity (ROE 16.8%)
- ✓Efficient capital deployment (ROCE 21.7%)
- ✓Attractively valued vs sector (P/E 23x vs industry 54.4x)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
VENUSREM · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 41.76% | 41.76% | 41.76% | 41.76% | 41.76% | 41.76% |
| FII | 1.59% | 1.48% | 1.06% | 1.18% | 1.11% | 1.34% |
| Public | 56.65% | 56.76% | 57.17% | 57.06% | 57.13% | 56.90% |
Latest News
All news →Venus Remedies issues updates on physical shares
*Venus Remedies issues updates on physical shares.* The company filed a disclosure related to physical share certificates, though details remain sparse. Such updates typically pertain to compliance or investor communication. Traders should monitor for further clarifications. 📊 *STOCKS:* VENUSREM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #PhysicalShares
Venus Remedies announces AGM date in newspaper notice
*Venus Remedies announces AGM date in newspaper notice.* This is a routine compliance requirement under corporate regulations. No financial or operational updates were provided. The filing ensures shareholders are informed of the upcoming annual general meeting. 📊 *STOCKS:* VENUSREM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Venus Remedies alerts shareholders to update KYC via social media
*Venus Remedies alerts shareholders to update KYC via social media.* The company issued a notice through a social media post to ensure shareholders complete their **KYC updates**. This move aims to improve compliance and communication with investors. No financial impact is expected from this routine update. 📊 *STOCKS:* VENUSREM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #KYC